Evidence map›Paper›PMID 30983154›Full record

ArticleProteomics2019

Integrated Transcriptomic and Proteomic Analysis of Primary Human Umbilical Vein Endothelial Cells.

Anil K Madugundu, Chan Hyun Na, Raja Sekhar Nirujogi, Santosh Renuse, Kwang Pyo Kim, Kathleen H Burns, Christopher Wilks, Ben Langmead, Shannon E Ellis, Leonardo Collado-Torres and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Proteomics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Spire1 and Myosin Vc promote CaCellular and molecular life sciences : CMLS · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Anil K MadugunduCenter for Molecular Medicine, National Institute of Mental Health and Neurosciences, Hosur Road, Bangalore, 560029, Karnataka, India.
Chan Hyun NaMcKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
Raja Sekhar NirujogiMcKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
Santosh RenuseMcKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
Kwang Pyo KimDepartment of Applied Chemistry, Kyung Hee University, Yongin, Gyeonggi, 17104, Republic of Korea.
Kathleen H BurnsMcKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
Christopher WilksDepartment of Computer Science, Johns Hopkins University, Baltimore, MD, 21218, USA.
Ben LangmeadDepartment of Computer Science, Johns Hopkins University, Baltimore, MD, 21218, USA.
Shannon E EllisCenter for Computational Biology, Johns Hopkins University, Baltimore, MD, 21205, USA.
Leonardo Collado-TorresCenter for Computational Biology, Johns Hopkins University, Baltimore, MD, 21205, USA.
Marc K HalushkaDepartments of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
Min-Sik KimDepartment of Applied Chemistry, Kyung Hee University, Yongin, Gyeonggi, 17104, Republic of Korea.ORCID 0000-0001-7317-5360
Akhilesh PandeyCenter for Molecular Medicine, National Institute of Mental Health and Neurosciences, Hosur Road, Bangalore, 560029, Karnataka, India.ORCID 0000-0003-4274-7316
Johns Hopkins University · USMayo Clinic · USDaegu Gyeongbuk Institute of Science and Technology · KRKyung Hee University · KR

Funding

Understanding Mechanisms of a-synuclein pathologyP50NS038377 · NINDS · JOHNS HOPKINS UNIVERSITY · PI DAWSON, TED M. · 1998 to 2019
$38.8M
The Comprehensive Proteome Characterization Center at Johns Hopkins: High Precision Discovery and Confirmation of Genoproteomic TargetsU24CA210985 · NCI · JOHNS HOPKINS UNIVERSITY · PI CHAN, DANIEL WANYUI, ZHANG, HUI · 2016 to 2020
$5.3M
Personalized Therapy of Hormone Refractory Breast CancerR01CA184165 · NCI · MAYO CLINIC ROCHESTER · PI PANDEY, AKHILESH · 2015 to 2019
$1.8M
Exonizaton of Alu Insertion PolymorphismsR01GM124531 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI BURNS, KATHLEEN H, FLOREA, LILIANA D · 2017 to 2020
$1.3M
Fourier Transform Orbitrap Fusion Lumos Tribrid Mass Spectrometer with ETDS10OD021844 · OD · JOHNS HOPKINS UNIVERSITY · PI PANDEY, AKHILESH · 2016 to 2016
$1.1M
DBT-Wellcome Trust India Alliance IA/M/15/1/502023NCI NIH HHS R01 CA184165NCI NIH HHS U24 CA210985NIGMS NIH HHS R01 GM124531NIH HHS P50NS038377NIH HHS R01CA184165NIH HHS R01GM124531NIH HHS S10 OD021844NIH HHS S10OD021844NIH HHS U24CA210985NINDS NIH HHS P50 NS038377Wellcome Trust
6 · The paper itself

Abstract

Understanding the molecular profile of every human cell type is essential for understanding its role in normal physiology and disease. Technological advancements in DNA sequencing, mass spectrometry, and computational methods allow us to carry out multiomics analyses although such approaches are not routine yet. Human umbilical vein endothelial cells (HUVECs) are a widely used model system to study pathological and physiological processes associated with the cardiovascular system. In this study, next-generation sequencing and high-resolution mass spectrometry to profile the transcriptome and proteome of primary HUVECs is employed. Analysis of 145 million paired-end reads from next-generation sequencing confirmed expression of 12 186 protein-coding genes (FPKM ≥0.1), 439 novel long non-coding RNAs, and revealed 6089 novel isoforms that were not annotated in GENCODE. Proteomics analysis identifies 6477 proteins including confirmation of N-termini for 1091 proteins, isoforms for 149 proteins, and 1034 phosphosites. A database search to specifically identify other post-translational modifications provide evidence for a number of modification sites on 117 proteins which include ubiquitylation, lysine acetylation, and mono-, di- and tri-methylation events. Evidence for 11 "missing proteins," which are proteins for which there was insufficient or no protein level evidence, is provided. Peptides supporting missing protein and novel events are validated by comparison of MS/MS fragmentation patterns with synthetic peptides. Finally, 245 variant peptides derived from 207 expressed proteins in addition to alternate translational start sites for seven proteins and evidence for novel proteoforms for five proteins resulting from alternative splicing are identified. Overall, it is believed that the integrated approach employed in this study is widely applicable to study any primary cell type for deeper molecular characterization.

Indexed as

Alternative SplicingHumansHuman Umbilical Vein Endothelial CellsProteomicsTranscriptomeallelic expressioncoding SNPmass-spectrometryproteoformproteogenomicsRNA-seqsplice variantstranscriptome

Identifiers

PMID30983154
PMCPMC6812510
OpenAlexW2938476529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.